DUBLIN--(BUSINESS WIRE)--Feb 8, 2019--The "Global Immunoprotein Diagnostic Testing Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.

The Global Immunoprotein Diagnostic Testing market is expected to reach $6.05 million by 2026 growing at a CAGR of 9.0% during the forecast period 2018-2026.

Immunoprotein refers to a blood protein that possesses immunological activity, which provides immunity against pathogenic organisms or substances as they display an unusual increase in blood concentration thereby acting as a potential indicator in disease diagnosis during an unhealthy state. The High prevalence of chronic diseases such as cancer, cardiovascular diseases, urological disorders, and orthopedic diseases are fueling the market.

However, stringent regulatory frameworks are responsible to restrain the market. The emerging technologies for the diagnosis of allergies are set to provide ample opportunities for the market.

Depending upon the technology, enzyme-based immunoassay held the highest market share and chemiluminescence is expected to grow with the highest growth rate during the forecast period. The growth of the enzyme-based immunoassay market is fueled by the expanding use of immunoassays in cancer, POC IVD testing, infectious disease testing, therapeutic drug level monitoring, and the introduction of novel biomarkers.

Key Topics Covered:

1 Market Synopsis

2 Research Outline

2.1 Research Snapshot

2.2 Research Methodology

2.3 Research Sources

3 Market Dynamics

3.1 Drivers

3.2 Restraints

4 Market Environment

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Immunoprotein Diagnostic Testing Market, By Technology

5.1 Introduction

5.2 Enzyme-based Immunoassay

5.3 Immunofluorescence Assay

5.4 Immunoprotein Electrophoresis

5.5 Immunoturbidity Assay

5.6 Radioimmunoassay

6 Global Immunoprotein Diagnostic Testing Market, By Application

6.1 Introduction

6.2 Oncology & Endocrinology Testing

6.3 Autoimmune Disease Testing

6.4 Infectious Disease Testing

6.5 Allergy Testing

6.6 Toxicology Testing

7 Global Immunoprotein Diagnostic Testing Market, By Geography

7.1 Introduction

7.2 North America

7.3 Europe

7.4 Asia Pacific

7.5 South America

7.6 Middle East & Africa

8 Strategic Benchmarking

9 Vendors Landscape

9.1 Randox Laboratories

9.2 Hoffmann-La Roche Ag

9.3 Abbott Laboratories

9.4 Abcam Plc

9.5 Bio-Rad Laboratories, Inc.

9.6 Siemens Healthcare GmbH

9.7 Thermo Fisher Scientific Inc

9.8 Danaher Corporation

9.9 Ortho Cllinical Diagnostics

9.10 AdnaGen

9.11 Agilent Technologies

9.12 Beckman Coulter, Inc.

9.13 bioMrieux SA

9.14 Enzo Biochem, Inc.

9.15 Diasorin S.P.A

9.16 Fujirebio Diagnostics, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/xvxkcb/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190208005210/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Diagnostics,In Vitro Diagnostics

KEYWORD:

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/08/2019 07:13 AM/DISC: 02/08/2019 07:13 AM

http://www.businesswire.com/news/home/20190208005210/en

Copyright Business Wire 2019.